SAN DIEGO, May 20, 2016 /PRNewswire/ -- Shareholder
Rights Law Firm Johnson & Weaver, LLP is investigating
potential claims against NewLink Genetics Corporation, DeVry
Education Group, Inc., Target Corporation, La Quinta Holdings Inc.
and Carbylan Therapeutics, Inc., as detailed below:
NewLink Genetics Corporation
Johnson & Weaver, LLP is investigating potential violations
of the federal securities laws by NewLink Genetics
Corporation (NASDAQ: NLNK) and certain of its officers. A class
action lawsuit against the Company has been filed on behalf of
shareholders who purchased NewLink betweenSeptember 17, 2013 and
May 9, 2016, (the "Class
Period").
The Complaint alleges that throughout the Class Period,
Defendants made false and/or misleading statements, as well as
failed to disclose material adverse facts about NewLink's business,
operations, and prospects. Specifically, Defendants made false
and/or misleading statements and/or failed to disclose that: (i)
the Company's algenpantucel-L treatment was ineffective and
potentially harmful to patients; and (ii) as a result of the
foregoing, NewLink's public statements were materially false and
misleading at all relevant times.
On May 9, 2016, post-market,
NewLink announced that algenpantucel-L did not meet the main goal
in the Company's Phase 3 IMPRESS study. Patients treated with
algenpantucel-L lived for a median of 27.3 months in NewLink's
Phase 3 trial, compared to median survival of 30.4 months for
patients treated with standard therapy, suggesting that patients
were actually harmed by NewLink's treatment.
On this news, NewLink's stock price dropped 30.61%, to close at
$11.45 on May
10, 2016.
If you have held shares continuously prior to September 2013, you may have standing to hold
NewLink harmless from the damage the officers and directors caused
by making them personally responsible. You may also be able to
assist in reforming the Company's corporate governance to prevent
future wrongdoing.
If you are a NewLink shareholder and are interested in
learning more about the investigation or your legal rights and
remedies, please contact lead analyst Jim
Baker (jimb@johnsonandweaver.com) at 619-814-4471. If you
email, please include your phone number.
DeVry Education Group, Inc.
Johnson & Weaver, LLP is investigating potential violations
of the federal securities laws by DeVry Education Group,
Inc. (NYSE: DV) and certain of its officers. A class action
lawsuit against the Company has been filed on behalf of
shareholders who purchased DeVry between February 4, 2011 and January 27, 2016. (the "Class Period").
The Complaint alleges that DeVry failed to disclose that: (1)
the Company was involved in a prolonged deceptive advertising
campaign; and (2) DeVry exaggerated its students' ability to secure
jobs after graduation.
If you have held shares continuously prior to February 2011, you may have standing to hold
DeVry harmless from the damage the officers and directors caused by
making them personally responsible. You may also be able to assist
in reforming the Company's corporate governance to prevent future
wrongdoing.
If you are a DeVry shareholder and are interested in learning
more about the investigation or your legal rights and remedies,
please contact lead analyst Jim
Baker (jimb@johnsonandweaver.com) at 619-814-4471. If you
email, please include your phone number.
Target Corporation
Johnson & Weaver, LLP is investigating potential violations
of the federal securities laws by Target Corporation (NYSE:
TGT) and certain of its officers. A class action lawsuit against
the Company has been filed on behalf of shareholders who purchased
Target between February 27, 2013 and
May 19, 2014, (the "Class
Period").
The complaint alleges that throughout the Class Period, Target
issued false and misleading statements to investors and failed to
disclose that: (1) at the time of the opening of Target's first
group of stores in Canada, Target
had significant problems with its supply chain infrastructure,
distribution centers, and technology systems, as well as
inadequately trained employees; (2) these problems caused
significant, pervasive issues, including excess inventory at
distribution centers and inadequate inventory at retail locations;
(3) the excess inventory at distribution centers and lack of
inventory at retail locations forced Target to heavily discount
products and incur heavy losses; and (4) the supply-chain and
personnel problems were not typical of newly launched locations in
Target's traditional U.S.-based market; and (5) as a result,
Target's public statements were materially false and misleading at
all relevant times. When the true details were known, the lawsuit
claims that investors suffered damages.
If you have held shares continuously prior to February 2013, you may have standing to hold
Target harmless from the damage the officers and directors caused
by making them personally responsible. You may also be able to
assist in reforming the Company's corporate governance to prevent
future wrongdoing.
If you are a Target shareholder and are interested in
learning more about the investigation or your legal rights and
remedies, please contact lead analyst Jim
Baker (jimb@johnsonandweaver.com) at 619-814-4471. If you
email, please include your phone number.
La Quinta Holdings Inc.
Johnson & Weaver, LLP is investigating potential violations
of the federal securities laws by La Quinta Holdings Inc
(NYSE: LQ) and certain of its officers. A class action lawsuit
against the Company has been filed on behalf of shareholders who
purchased La Quinta between
February 25, 2015 and September 17, 2015, (the "Class Period").
The complaint alleges throughout the Class Period La Quinta
issued false and misleading statements to investors and failed to
disclose that: (1) La Quinta was
experiencing declining customer demand in its key Texas market; (2) there were on-going
disruptions caused by the transitioning of La Quinta's call center operations; (3)
La Quinta was experiencing
declining customer demand and market share losses due in part to
certain of La Quinta's facilities
being outdated and in need of major renovation, thus necessitating
significant capital expenditures and operational disruptions; and
(4) as a result, La Quinta's
public statements were materially false and misleading. When the
true details entered the market, the lawsuit claims that investors
suffered damages.
If you are a La Quinta
shareholder and are interested in learning more about the
investigation or your legal rights and remedies, please contact
lead analyst Jim Baker
(jimb@johnsonandweaver.com) at 619-814-4471. If you email, please
include your phone number.
Carbylan Therapeutics, Inc.
Johnson & Weaver, LLP is investigating potential violations
of the federal securities laws by Carbylan Therapeutics,
Inc. (NASDAQ: CBYL) and certain of its officers in connection
with the Company's initial public offering (IPO). Specifically,
Johnson & Weaver's investigation seeks to determine whether
certain statements regarding the Company's business metrics and
financial prospects were not as strong as represented in the
Registration Statement.
On May 12, 2016 the Company
reported net losses of approximately $6.6
million and $5.2 million in
the three months ended March 31, 2016
and 2015, respectively.
If you have information that could assist in this investigation,
or if you are a Carbylan shareholder who suffered a loss on that
investment and are interested in learning more about the
investigation or your legal rights and remedies, please contact
Jim Baker
(jimb@johnsonandweaver.com) by email or by phone at
619-814-4471. If emailing, please include a phone number where you
can be reached.
About Johnson & Weaver, LLP:
Johnson & Weaver, LLP is a nationally recognized shareholder
rights law firm with offices in California, New
York and Georgia. The firm
represents individual and institutional investors in shareholder
derivative and securities class action lawsuits. For more
information about the firm and its attorneys, please visit
http://www.johnsonandweaver.com. Attorney advertising. Past results
do not guarantee future outcomes.
Contact:
Johnson & Weaver, LLP
Jim Baker, 619-814-4471
jimb@johnsonandweaver.com
Logo - http://photos.prnewswire.com/prnh/20160211/332409LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/shareholder-rights-law-firm-johnson--weaver-llp-initiates-investigations-of-newlink-genetics-corporation-devry-education-group-inc-target-corporation-la-quinta-holdings-inc-and-carbylan-therapeutics-inc-encourages-inves-300272674.html
SOURCE Johnson & Weaver, LLP